Advanced Viral Research CP (ADVR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Viral Research CP (ADVR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RickV who wrote (1857)	12/11/1996 12:07:00 PM
From: .com	of 2281

Thanks Rick. Now that's lingo I can understand; I wish that ADVR would put it that way. It does not seem that the street cares too much about, or in all probability, understand their press release. Another problem is that it was not even on the Dow Jones wire service. I thought they had hired a PR service to help with this stuff. I understand the need for caution in this industry, but it couldn't hurt to get the word out on the major wire services and even to discuss the potential implications of the research report. I noticed they referred to it as a preliminary report, so manybe they have something more planned for later when a final report is released. Or, another possibility is that they are awaiting publication of the final report in a medical journal (to help beef up resumes) and don't want to steal the thunder from that. Obviously, what little was released in their press release was not enough to start any discussion in the medical community. Only problems with waiting (other than falling stock prices) is that it takes 3-4 months to get something published and many folks who could potentially be helped by the drug won't be able to get it for many more months. They said they hope to start the next testing satages for FDA approval. Didn't the need more cash for that, and an additional $2million to keep Hirschman on board? Does anybody nknow anything about this issue? If they are just starting the FDA testing process, and submitting an application, it can take years for this to get through. Hopefully they will apply as an AIDS drug and can get an expedited review classification. Does anyone know, and can explain, the steps needed for FDA approval if they are just now submitting an application? What kind of testing nust be done? What is the review and approval process like? Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next